This is the authors' abstract. We don't add key points for this paper.
Supplementary Figure S4. Kaplan–Meier graphs of comparisons between patients with ctHPV DNA–positive (dotted, bottom lines) and ctHPV DNA–negative (solid, top lines) plasma at early-follow up/tumor evaluation (1-4 month after finished treatment) plasma.
No takes yet. Share an insight, caveat, or question.
Sivars et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: